Cargando…
KDM5A controls bone morphogenic protein 2-induced osteogenic differentiation of bone mesenchymal stem cells during osteoporosis
Bone morphogenetic protein 2 (BMP2) has been used to induce bone regeneration by promoting osteogenic differentiation of bone marrow-derived mesenchymal stem cells (MSCs). However, its effect is attenuated in osteoporotic conditions by unknown mechanisms. In this study, we investigated the molecular...
Autores principales: | Wang, Chuandong, Wang, Jing, Li, Jiao, Hu, Guoli, Shan, Shengzhou, Li, Qingfeng, Zhang, Xiaoling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5108323/ https://www.ncbi.nlm.nih.gov/pubmed/27512956 http://dx.doi.org/10.1038/cddis.2016.238 |
Ejemplares similares
-
TSG Targeting KDM5A Affects Osteogenic Differentiation of Bone Mesenchymal Stem Cells Induced by Bone Morphogenetic Protein 2
por: Wei, Min, et al.
Publicado: (2022) -
To B (Bone Morphogenic Protein-2) or Not to B (Bone Morphogenic Protein-2): Mesenchymal Stem Cells May Explain the Protein’s Role in Osteosarcomagenesis
por: Xu, Chunfeng, et al.
Publicado: (2021) -
Raloxifene improves TNF-α-induced osteogenic differentiation inhibition of bone marrow mesenchymal stem cells and alleviates osteoporosis
por: Yang, Fenghe, et al.
Publicado: (2020) -
Loss of KDM4B impairs osteogenic differentiation of OMSCs and promotes oral bone aging
por: Deng, Peng, et al.
Publicado: (2022) -
Applying vibration in early postmenopausal osteoporosis promotes osteogenic differentiation of bone marrow-derived mesenchymal stem cells and suppresses postmenopausal osteoporosis progression
por: Li, Huiming, et al.
Publicado: (2019)